DEFINITIVE PROXY STATEMENT

Company

INOVIO PHARMACEUTICALS, INC.

Filed

April 4, 2002

Period of Report

April 29, 2002

Accession Number

0000936392-02-000397

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →